KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 104 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,038,633 | +187.5% | 865,782 | +133.0% | 0.00% | +200.0% |
| Q2 2023 | $5,230,973 | +15.2% | 371,518 | -11.9% | 0.00% | 0.0% |
| Q1 2023 | $4,539,999 | -70.2% | 421,933 | -58.5% | 0.00% | -66.7% |
| Q4 2022 | $15,218,302 | +30.9% | 1,015,908 | +12.2% | 0.00% | 0.0% |
| Q3 2022 | $11,624,000 | +89.2% | 905,268 | +42.8% | 0.00% | +200.0% |
| Q2 2022 | $6,143,000 | -34.0% | 633,904 | -32.3% | 0.00% | -50.0% |
| Q1 2022 | $9,310,000 | +36.6% | 936,604 | +61.7% | 0.00% | +100.0% |
| Q4 2021 | $6,817,000 | +22.3% | 579,217 | +18.3% | 0.00% | 0.0% |
| Q3 2021 | $5,576,000 | -5.5% | 489,573 | +15.5% | 0.00% | 0.0% |
| Q2 2021 | $5,902,000 | -25.0% | 423,696 | -0.3% | 0.00% | -50.0% |
| Q1 2021 | $7,869,000 | -20.4% | 425,161 | -24.0% | 0.00% | -33.3% |
| Q4 2020 | $9,881,000 | +464.0% | 559,210 | +389.0% | 0.00% | – |
| Q3 2020 | $1,752,000 | -18.3% | 114,357 | +35.9% | 0.00% | -100.0% |
| Q2 2020 | $2,144,000 | +510.8% | 84,128 | +270.7% | 0.00% | – |
| Q1 2020 | $351,000 | +134.0% | 22,697 | +67.6% | 0.00% | – |
| Q4 2019 | $150,000 | -69.9% | 13,543 | -76.9% | 0.00% | – |
| Q3 2019 | $499,000 | +162.6% | 58,634 | +317.8% | 0.00% | – |
| Q2 2019 | $190,000 | -39.7% | 14,033 | -19.7% | 0.00% | – |
| Q1 2019 | $315,000 | -79.8% | 17,469 | -80.6% | 0.00% | – |
| Q2 2018 | $1,563,000 | – | 90,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |